Previous 10 | Next 10 |
BERKELEY, Calif. and MAINZ, Germany, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announces that Guido Baechler, Chief Executi...
Mainz Biomed N.V. (MYNZ) is expected to report $-0.5 for Q3 2023
2023-11-16 10:40:24 ET More on Mainz Biomed B.V. Mainz Biomed announces pricing of $5M registered direct offering Mainz Biomed gains after trial data for colorectal cancer test Seeking Alpha’s Quant Rating on Mainz Biomed B.V. Historical earnings data ...
ColoAlert ® Revenue Increases 102% Year Over Year for the Nine Months Ended September 30, 2023 ColoFuture Study Reported Groundbreaking Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 80% BERKELE...
BERKELEY, Calif. and MAINZ, Germany, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (Nasdaq: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced the closing of its previous...
2023-11-13 12:36:46 ET Gainers: Tenax Therapeutics ( TENX ) +310% . Tivic Health Systems ( TIVC ) +71% . Montauk Renewables ( MNTK ) +28% . Sohu.com Ltd. ( SOHU ) +24% . INVO Bioscience ( INVO ) +26% . Direct Digital Holdings...
2023-11-13 10:00:35 ET More on Mainz Biomed B.V. Mainz Biomed gains after trial data for colorectal cancer test Mainz Biomed expands footprint in Germany with new partnership Seeking Alpha’s Quant Rating on Mainz Biomed B.V. Historical earnings data fo...
2023-11-13 10:00:16 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
BERKELEY, Calif. and MAINZ, Germany, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (Nasdaq: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that it has entered into a ...
BERKELEY, Calif. and MAINZ, Germany, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a strategic partnership wi...
News, Short Squeeze, Breakout and More Instantly...
Mainz Biomed B.V. Company Name:
MYNZ Stock Symbol:
NASDAQ Market:
BERKELEY, Calif. and MAINZ, Germany, May 31, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, held its annual general meeting (“Annual General Meeting”) on Friday, May 31, 2024 in Amster...
Shares of Ooma, Inc. (NYSE:OOMA) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter fina...
Key Findings: 92.3% Sensitivity for Colorectal Cancer, 82.3% for Advanced Precancerous Lesions Poster presentation showing new data on 690 subject...